Results 141 to 150 of about 54,427 (263)

Biologic treatments in rheumatoid arthritis and juvenile idiopathic arthritis [PDF]

, 2006
A number of biological approaches to the management of inflammtory arthropathies have been explored. These include the development of IL-1 receptor antagonists and TNF antagonists. Four biological agents are currently marketed in Europe.
Borg, Andrew A.
core  

HLA-DRB1 alleles in juvenile-onset systemic lupus erythematosus: renal histologic class correlations

Brazilian Journal of Medical and Biological Research, 2007
Human leukocyte antigens (HLA) DRB1*03 and DRB1*02 have been associated with systemic lupus erythematosus (SLE) in Caucasians and black populations. It has been observed that certain HLA alleles show stronger associations with SLE autoantibodies and ...
B.L. Liphaus, M.H.B. Kiss, A.C. Goldberg
doaj  

Case Report: Diagnostic itinerary of a male case of juvenile-onset systemic lupus erythematosus in Bouake

Frontiers in Pediatrics
Juvenile-onset systemic lupus erythematosus (JLES) is an autoimmune disease of unknown aetiology. It is more common in girls but can occur in boys. Its onset at an early age is more severe, causing potentially fatal damage if not treated early.
Aissata Doucoure Traore, Aissata Doucoure Traore, Joseph Kan Enock Koffi, Joseph Kan Enock Koffi, Christ Ziahy Reine Marie Koffi, Christ Ziahy Reine Marie Koffi, Konan Joe Clovis Yao, Konan Joe Clovis Yao, Jean Jacque Goua, Jean Jacque Goua, Ehaulier Soh Christian Kouakou, Ehaulier Soh Christian Kouakou, Weu Melanie Tia, Weu Melanie Tia, Felix Jean Claude Daboiko, Felix Jean Claude Daboiko   +15 more
doaj   +1 more source

Heterogeneity of macrophage activation syndrome and treatment progression

Frontiers in Immunology
Macrophage activation syndrome (MAS) is a rare complication of autoimmune inflammatory rheumatic diseases (AIIRD) characterized by a progressive and life-threatening condition with features including cytokine storm and hemophagocytosis.
Yuanji Dong, Ting Wang, Huaxiang Wu
doaj   +1 more source

Adding to complexity: comorbidity in paediatric rheumatic disease [PDF]

, 2012
Beresford, Michael W, Foster, Helen E, Smith, Eve MD   +2 more
core   +1 more source

THE USAGE OF INTRAVENOUS CYCLOPHOSPHAMIDE IN JUVENILE ONSET LUPUS AND ITS GESTACIONAL RESULTS IN ADULTHOOD

Blucher Medical Proceedings, 2019
F. V. Leão, R. Gomes, B. Bica
semanticscholar   +1 more source

Oral Ulcers in Juvenile-Onset Systemic Lupus Erythematosus: A Review of the Literature [PDF]

, 2017
Beresford, Michael W, Chiewchengchol, Direkrit, Deekajorndech, Tawatchai, Edwards, Steven W, Prueksrisakul, Titipong, Rodsaward, Pongsawat   +5 more
core   +1 more source

Type I interferon associated epistasis may contribute to early disease-onset and high disease activity in juvenile-onset lupus.

Clinical Immunology
Y. Renaudineau, A. Charras, V. Natoli, M. Fusaro, E. Smith, Michael W. Beresford, C. Hedrich   +6 more
semanticscholar   +1 more source

10. Juvenile-onset lupus nephritis: Characterising the role of the glomerular endothelial cells in urinary biomarker production

, 2017
P. Dimou, M. Peak, A. Midgley, S. Satchell, RD Wright, M. Beresford   +5 more
semanticscholar   +1 more source

Presence of tubuloreticular inclusions in ultrastructural studies of renal biopsies in children with lupus nephropathy – one-center preliminary study

Central European Journal of Immunology, 2023
Tomasz Koszutski, Łukasz Mielańczyk, Grażyna Kucharska, Natalia Matysiak, Agnieszka Wiernik, Grzegorz Kudela, Lidia Hyla-Klekot   +6 more
doaj   +1 more source